Physician profile
Susan E Vance
NPI 1578669578
$4,664.30
in general payments reported to CMS, 2019-2025
39 companies · $723 in 2025
The $723 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $238 · 2021: $788 · 2022: $781 · 2023: $824 · 2024: $649 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.52 |
| Education | $238.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.06 | 2019-2023 | Orilissa, Lo Loestrin Fe, Oriahnn |
| Astellas Pharma US INC | $595.30 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $370.94 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $335.59 | 2023-2025 | Myfembree, Gemtesa |
| Mylan Pharmaceuticals INC. | $297.06 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $235.05 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $192.75 | 2019-2025 | |
| Millicent US INC | $179.94 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $179.43 | 2022-2025 | Nexplanon, Jada System |
| Exeltis, USA INC. | $172.94 | 2019-2025 | Slynd |
| Myovant Sciences INC. | $162.89 | 2021-2022 | |
| Shield Therapeutics INC | $139.35 | 2024-2025 | |
| Therapeuticsmd, INC. | $105.62 | 2019-2022 | |
| Coopersurgical, INC. | $94.65 | 2021-2025 | Summit Doppler, Paragard T 380a, Paragard T 380a |
| Sage Therapeutics, LLC | $88.27 | 2024-2025 | Zurzuvae |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.